American Association for the Study of Liver Diseases and Taiwan Association for the Study of the Liver Community Conversation: Precision Management of Chronic Hepatitis B

Description

This year's American Association for the Study of Liver Diseases and Taiwan Association for the Study of the Liver joint community conversation program highlights updates on the current status, regional and shared challenges and unmet needs, and emerging strategies toward precision management of chronic hepatitis B.

Presentations

3:45 PM - 3:55 PM
Convention Center - Bluebird Ballroom 2GH

Finite Anti–Hepatitis B Virus Therapy and Its Long-term Outcomes

Rachel Wen-Juei Jeng, MD, PhD | Presenter
3:55 PM - 4:05 PM
Convention Center - Bluebird Ballroom 2GH

Unmet Needs and Emerging Solutions in the Management of Chronic Hepatitis B

Chanda Ho, MPH, MD, FAASLD | Presenter
4:05 PM - 4:15 PM
Convention Center - Bluebird Ballroom 2GH

Strategies and Challenges in Linking Patients Living With Hepatitis B to the Health Care System for Treatment

Yao-Chun Hsu | Presenter
4:15 PM - 4:25 PM
Convention Center - Bluebird Ballroom 2GH

Management of Hepatitis B virus Infection With Coexisting Metabolic Dysfunction–Associated Steatotic Liver Disease

Mindie Nguyen | Presenter

Objectives

  • Review the current gaps and unmet needs in the care of chronic hepatitis B in Taiwan and the US, considering national and international guidelines for hepatitis B.
  • Identify emerging solutions to improve the control of chronic hepatitis B and its complications.
  • Discuss regional and global strategies to accomplish the goals of precision management of chronic hepatitis B and hepatitis B elimination.